All updates
All updates
today 30文献与产业新闻评分4646 文献与产业新闻精选评分6161 Selective oestrogen receptor degrader class grows with new cancer approval
文献与产业新闻评分2020 In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
文献与产业新闻评分1818 STAT+: Right before midterms, Trump dangles $500 refunds for select ACA enrollees
文献与产业新闻评分2727 STAT+: FDA expands Bayer lung cancer drug approval
文献与产业新闻评分2626 STAT+: Cancer medicines remain in short supply across the U.S., survey finds
文献与产业新闻精选评分5757 In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage
文献与产业新闻精选评分5858 Biohaven epilepsy drug suffers FDA hold days after attracting $350M deal
文献与产业新闻评分1515 Independent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcare
文献与产业新闻精选评分6565 Moderna flu vaccine wins FDA approval
文献与产业新闻精选评分4444 FDA approves oncolytic virus
文献与产业新闻精选评分4040 STAT+: U.K. unveils recommendations for regulating AI in medicine
文献与产业新闻评分1717 Michael Davis: A firm hand on CDER’s tiller
文献与产业新闻精选评分5555 FDA clears Bayer’s Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry
文献与产业新闻评分1818 STAT+: Orexin discoverers awarded prestigious Lasker award
中文产业新闻精选Chinese source评分7070 阿斯利康 camizestrant 联合 CDK4/6 抑制剂获 FDA 加速批准用于 ESR1 突变乳腺癌
顶刊论文（社媒热度）精选评分2626 A binding ban, and its limits: Japan legislates on heritable human genome editing.
文献与产业新闻精选评分3838 FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits
文献与产业新闻评分2222 FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits
文献与产业新闻评分3030 Abbott garners FDA nod for its TactiFlex catheter to treat AFib
文献与产业新闻精选评分4949 STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
文献与产业新闻评分3131 STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
文献与产业新闻评分3535 Making center directors permanent latest signal of stability for FDA
中文产业新闻精选Chinese source评分6767 FDA 批准 TYK2/JAK1 双重抑制剂 brepocitinib 用于成人皮肌炎
文献与产业新闻评分2020 An administrative gap delays access to new pancreatic cancer treatment
文献与产业新闻精选评分4949 A breakthrough pancreatic cancer drug won approval. They still struggle to access it
文献与产业新闻评分1313 Reynolds is selling fruity new vapes unauthorized by FDA
中文产业新闻精选Chinese source评分6565 国家医保局发布 DRG/DIP 3.0 版分组方案
中文产业新闻精选Chinese source评分6767 阿斯利康camizestrant联合CDK4/6抑制剂方案获FDA加速批准
中文产业新闻精选Chinese source评分6161 礼来 Mounjaro 凭 SURPASS-CVOT 非劣效结果再获 FDA 批准用于降低 2 型糖尿病 MACE 风险
中文产业新闻精选Chinese source评分6565 泰诺麦博 RSV 单抗芮特韦拜单抗获 NMPA 批准上市，单次注射保护 9 个月
中文产业新闻精选Chinese source评分6464 GSK的反义寡核苷酸疗法bepirovirsen日本获批 用于慢性乙肝功能性治愈
文献与产业新闻评分2929 Six first-in-class approvals in August
FDA Press Releases精选评分3535 FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products
FDA Press Releases精选评分5959 FDA Grants Accelerated Approval to a New Breast Cancer Treatment
文献与产业新闻评分1010 STAT+: FDA takes another look at botanical drugs
中文产业新闻精选Chinese source评分7575 FDA批准Revolution Medicines RAS(ON)分子胶daraxonrasib治疗转移性胰腺腺癌
文献与产业新闻精选评分4343 Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
文献与产业新闻精选评分4949 Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
EMA News精选评分4545 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2026